Today, we invite you to join us in defending the foundation of American science. SRF Chairman and scleroderma patient Luke Evnin, PhD, has partnered with Peter Rubin of No Patient...
Read More
Groundbreaking clinical study recently launched to accelerate clinical development of new treatments for scleroderma Journal of Scleroderma and Related Disorders outlines protocol and rationale for two initial investigational drugs San...
Read More
Here at the Scleroderma Research Foundation, research is at the center of all we do to find a cure—and that's only possible because of the dedicated support of our community....
Read More
SRF-funded researcher Dr. Howard Chang shares a breakthrough discovery he & his collaborators made, shedding light on why women are more likely than men to develop autoimmune diseases like #scleroderma,...
Read More
Nearly 90% of those with scleroderma have Raynaud’s symptoms. This is why Raynaud’s can be a “red flag” that helps lead to diagnosis and treatment of scleroderma. And for Aneila, dx…
February is Rare Disease Awareness Month. It's an opportunity for us to come together and raise awareness about what it means to live with a rare disease like #scleroderma. To...
Read More
Dr. Gordon will have oversight over the SRF’s global clinical trial program CONQUEST and will contribute to the research program across the SRF portfolio San Francisco, CA (January 25, 2024)…
In 2018, the SRF launched the CONQUER Registry (COllaborative National Quality and Efficacy Registry) – a first-of-its-kind longitudinal, nationwide patient registry and biosample repository aimed at improving care and developing...
Read More
FDA clears IND to launch CONQUEST trial platform with initial focus on Interstitial Lung Disease Secondary to Scleroderma (SSc-ILD) SCLERODERMA RESEARCH FOUNDATION (SRF) holds the IND as trial Sponsor Sanofi...
Read More
In our last eNews of the year, read about exciting research updates, like how CONQUEST has recieved the FDA's OK to proceed, and how CONQUER has already result in 6...
Read More
